Mips Logo

Mips

Licenses patented helmet technology to reduce rotational impact injuries in sports and construction.

MIPS | ST

Overview

Corporate Details

ISIN(s):
SE0009216278 (+4 more)
LEI:
549300LZSA4S0L54VQ25
Country:
Sweden
Address:
Kemistvägen 1B, 183 79 TÄBY
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Mips is a developer of helmet-based safety technology focused on reducing head injuries. Its core product is the Mips® Safety System (Multi-Directional Impact Protection System), a patented Brain Protection System (BPS). Born from scientific research by a brain surgeon and a biomechanics scientist, the system incorporates a low-friction layer inside helmets. This layer is designed to move slightly upon an angled impact, helping to redirect harmful rotational motion away from the head and potentially reducing the risk of certain brain injuries. Mips licenses its technology to numerous helmet manufacturers for use in products across a wide range of markets, including cycling, snow sports, motorcycling, equestrian, and construction.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-22 07:30
Quarterly Report
Swedish 2.2 MB
2025-10-22 07:30
Quarterly Report
English 2.2 MB
2025-07-16 07:30
Earnings Release
Swedish 1.9 MB
2025-07-16 07:30
Earnings Release
English 1.9 MB
2025-05-07 11:45
AGM Information
Kommuniké från årsstämman i Mips AB (publ) den 7 maj 2025
Swedish 36.0 KB
2025-05-07 11:45
AGM Information
Press release from the Annual General Meeting in Mips AB (publ) on 7 May 2025
English 33.4 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.2 MB
2025-04-24 07:30
Quarterly Report
English 1.2 MB
2025-03-20 17:20
Annual Report (ESEF)
Swedish 2.5 MB
2025-02-05 18:10
Earnings Release
Mips updates long-term financial target
English 39.4 KB
2025-02-05 18:10
Report Publication Announcement
Mips uppdaterar långsiktigt finansiellt mål
Swedish 39.3 KB
2025-02-05 18:10
Earnings Release
Swedish 3.0 MB
2025-02-05 18:10
Annual Report
English 3.0 MB
2024-10-24 07:30
Quarterly Report
Swedish 1.3 MB
2024-10-24 07:30
Interim / Quarterly Report
English 1.4 MB

Automate Your Workflow. Get a real-time feed of all Mips filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mips

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mips via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-10-25 Thomas Bräutigam Other Sell 4,500 2,430,000.00 SEK
2023-09-14 John Fredrik Kjellberg Other Sell 10,300 3,705,837.00 SEK
2023-03-03 Maria Hedengren Other Buy 200 98,254.00 SEK
2022-10-18 Thomas Bräutigam Other Buy 2,000 609,594.40 SEK
2022-10-17 Thomas Bräutigam Other Buy 3,000 907,927.80 SEK
2022-05-06 Thomas Bräutigam Other Buy 1,000 580,600.00 SEK
2022-05-05 Thomas Bräutigam Other Buy 2,000 1,253,200.00 SEK
2022-03-07 Jonas Rahmn Other Buy 107 75,301.25 SEK
2022-03-07 Jonas Rahmn Other Buy 94 66,317.00 SEK
2022-03-07 Jonas Rahmn Other Buy 90 63,495.00 SEK

Peer Companies

SanBio Company Limited Logo
Developing regenerative cell therapies for severe neurological disorders like brain injury and stroke.
Japan
4592
SANGAMO THERAPEUTICS, INC Logo
Developing genomic cures for severe genetic diseases using proprietary zinc finger technology.
United States of America
SGMO
S.Biomedics Co., Ltd. Logo
South Korea
304360
SCANCELL HOLDINGS PLC Logo
Developing therapeutic vaccines and antibodies for cancer and infectious diseases.
United Kingdom
SCLP
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark
SCOL
Scanway Spolka Akcyjna Logo
Develops optical instruments for space and AI vision systems for industrial quality control.
Poland
SCW
Scholar Rock Holding Corp Logo
Biopharma developing medicines for neuromuscular diseases by targeting protein growth factors.
United States of America
SRRK
Schrodinger, Inc. Logo
A physics-based computational platform for accelerated drug and materials discovery.
United States of America
SDGR
South Korea
246960
Scope Fluidics S.A. Logo
Biotech venture builder creating microfluidic diagnostic systems for healthcare.
Poland
SCP

Talk to a Data Expert

Have a question? We'll get back to you promptly.